Zoghbi Huda Y sold $7.2M of REGN
Zoghbi Huda Y sold 7,439 shares of REGENERON PHARMACEUTICALS, INC. (REGN) at an average of $970.46 ($970.42–$971.06, $7.22M total) across 2 trades on 2026-11-03.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider holdings, useful for short-term sentiment assessment.
Market read
Insider sale of $7.2M may cause slight bearish pressure on REGN; traders should monitor price action and any further insider activity.
What to watch
Potential upcoming clinical trial results or earnings could dominate price action, dwarfing the insider sale.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Director Zoghbi Huda Y sold 7,439 shares of Regeneron for $7.2M via open-market transactions on 2026-11-03.
likely downward pressure as the market prices in the insider sell
A $7.2M sale by a director is material but not large enough to trigger a major move; traders may watch for further insider activity.
Market effects
Minimal impact on biotech sector; insider sales are common and usually isolated.
No regional effect beyond Regeneron's share price.
Limited to Regeneron investors; no broader market relevance.
Counterpoint
The sale could be unrelated to confidence, perhaps for personal liquidity, and may not affect the stock.
Key entities
- CompanyRegeneron Pharmaceuticals, Inc.
Biotech firm developing therapeutic antibodies.
- IndividualZoghbi Huda Y
Director at Regeneron who sold shares.
